Scientists hunt for early warning signs of rare brain diseases
NCT ID NCT05124392
Summary
This study aims to find early biological signs in people who carry a genetic risk for rare, fatal brain diseases like Creutzfeldt-Jakob Disease (CJD). Researchers will track 150 at-risk participants over time through annual check-ups, blood tests, spinal fluid collection, and memory tests. The goal is to learn how to predict when symptoms might start and to prepare for future treatment trials.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CJD (CREUTZFELDT JAKOB DISEASE) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Alzheimer's Clinical and Translational Research Unit
RECRUITINGCharlestown, Massachusetts, 02129, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.